Omeprazole PCD Pharma Franchise Company
Cafoli Lifecare is a leading Omeprazole PCD pharma franchise company in India, offering 20 Omeprazole formulations across capsules, tablets, sachets and injection — one of the deepest gastro ranges in our portfolio. All products are manufactured at WHO-GMP certified, DCGI-approved facilities and offered with exclusive district-wise monopoly rights.
What is Omeprazole?
Omeprazole is a proton pump inhibitor (PPI). It is a prodrug that accumulates in the acidic secretory canaliculi of the gastric parietal cell, where it is converted to its active form and irreversibly binds the H+/K+-ATPase enzyme — the "proton pump" that performs the final step of gastric acid secretion. This produces a profound and long-lasting reduction in stomach acid. It is used in acid-peptic disorders including gastro-oesophageal reflux disease and peptic ulcer, and as part of Helicobacter pylori eradication regimens. It is listed on the WHO Model List of Essential Medicines.
Available Omeprazole Formulations
The Cafoli Lifecare Omeprazole range comprises 20 formulations in the following dosage forms:
- Capsules
- Tablets
- Sachets
- Injection
Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the current Omeprazole price list.
Therapeutic Applications of Omeprazole
Prescribed under medical supervision for:
- Gastro-oesophageal reflux disease (GERD) and erosive oesophagitis
- Gastric and duodenal ulcer
- Helicobacter pylori eradication, as part of combination therapy
- NSAID-associated ulcer treatment and prophylaxis
- Zollinger-Ellison syndrome and other hypersecretory states
- Acid suppression in hospitalised and peri-operative patients (injection)
Prescriber specialties: gastroenterologists, consulting physicians, general and orthopaedic surgeons and paediatricians. Omeprazole is a prescription-only medicine; long-term use should be periodically reviewed by the treating doctor.
Why Omeprazole is a High-Potential Molecule for Distributors
Omeprazole is the classic "attach-rate" molecule, and that is what makes it structurally valuable rather than merely large. It is very rarely the primary prescription — instead it is added alongside NSAIDs, steroids, antibiotics and post-operative regimens to protect the gastric mucosa. The practical consequence for a franchise partner is that Omeprazole volumes rise automatically as the rest of the line card sells: every analgesic, antibiotic and surgical prescription tends to pull a PPI with it. On top of that attach business sits genuine primary demand — acid-peptic disease is extremely prevalent in India, and GERD is chronic and relapsing, so patients return for repeat courses indefinitely. The 20-formulation range covers retail capsules and tablets, paediatric-friendly sachets and hospital injection, letting one monopoly allotment serve chemists, clinics and nursing homes alike. Few molecules combine this much baseline volume with this little selling effort.
Why Choose Cafoli Lifecare
- Monopoly rights — exclusive district-wise marketing rights across all 20 Omeprazole formulations
- WHO-GMP certified manufacturing and DCGI-approved products
- Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
- 1000+ franchise partners across India with an on-time dispatch record
- Transparent net rates and dedicated franchise support
References
- WHO Model List of Essential Medicines
- PubChem — Omeprazole compound record
- PubMed — Omeprazole in acid-peptic disease
Our formulations of Omeprazole find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: